← Leaderboards
Craig Sherman
Hope Pharmaceuticals
$2,136,424
Attributed
$2,136,424
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2009–11$2M$1.5M$1M$500K$0
'09
'10
'11
Funding mix
By agency
NIH$2,136,424 · 2
By mechanism
R44$1,899,507 · 1
R43$236,917 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Intravenous”
- Lawrence Corey · Fred Hutchinson Cancer Center$298,997,339
- Carol Nesel · Westat$188,148,170
- David Heimbrook · Leidos Biomedical Research, Inc.$114,270,394
- Barbara Driver · Westat, Inc.$95,724,261
- Scott M Hammer · Columbia University Health Sciences$89,037,508
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$89,037,508
Research focus
IntravenousPharmacologic SubstanceEvaluationInjection Of Therapeutic AgentLegal PatentNitritesAccountingDrug KineticsHourInfusion ProceduresDesignDoseMorbidity - Disease RateMortality Vital StatisticsBlood FlowBusinessesClinical ResearchContinuous Intravenous InfusionComplicationHealthy VolunteerApplications GrantsCessation Of LifeAreaPrevent
Grant awards (4)
Prevention of Delayed Cerebral Vasospasm Associated with Subarachnoid Hemorrhage$1,000,000
R44 · FY2011 · NS · contact PI
Prevention of Delayed Cerebral Vasospasm Associated with Subarachnoid Hemorrhage$799,507
R44 · FY2010 · NS · contact PI
Prevention of ischemia reperfusion injury associated with acute myocardial infarc$236,917
R43 · FY2010 · HL · contact PI
Prevention of Delayed Cerebral Vasospasm Associated with Subarachnoid Hemorrhage$100,000
R44 · FY2009 · NS · contact PI